Standard Contracts
Underwriting AgreementUnderwriting Agreement • January 27th, 2017 • Braeburn Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Braeburn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [·] shares of Common Stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [·] shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • January 27th, 2017 • Braeburn Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS COMMON STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of January 26, 2017, by and between Braeburn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Apple Tree Partners IV, L.P., a Cayman Islands exempted limited partnership (“Purchaser”).
